Objective: Cardiac myxoma is the most common benign heart tumor. In this study, early and mid-term results of patients who underwent intracardiac myxoma exicision surgery were examined.
INTRODUCTION
Intracardiac myxoma is the most common tumor of the heart with an estimated incidence of 0.5 cases per million people per year and composes approximately 70% of all cardiac tumors (1) . Approximately 75% of these tumors arise from left atrium (LA) and 5-20 %from the right atrium (RA), 5% from both atria or the ventricle (2) . With the improvement of new diagnostic modalities, especially two-dimensional echocardiography, the diagnosis has been easier and less hazardous. In 1954, Crawford successfully excised a myxoma from the left atrium using cardiopulmonary bypass (3) . Surgical intervention offers a potential for cure. The aim of this study was to review the presentation, treatment, and prognosis of atrial myxomas and review the early and late results outcome after myxoma excision.
METHODS

Study Setting and Design
The study was designed as a retrospective observational case study. From February 1988 to December 2012, 31 consecutive patients surgically treated for intracardiac myxomas in our center were studied.
Patients and Study Evaluations
Eighteen (58.1%) were female and 13 patients (41.9%) were male, and the median age was 56 years (range. from 33 to 78 years) ( Table 1 ). There were 12 LA myxomas (38.7%), 19 RA myxomas (61.2%). All patients with RA myxoma presented with features of right heart failure and all patients with LA myxoma mimicked mitral stenosis clinically. One patient with LA myxoma (3.2%) was admitted to the Emergency Department with a history of sudden onset weakness of both lower limbs and abnormal movement of the upper limb one day prior to admission. On neurological examination, he had findings of cerebral stroke. On physical examination, he had mitral obstructive symptoms. The clinical profile of the patient is shown in Table 1 . Preoperative diagnosis was established in all patients by transthoracic two-dimensional (2D) echocardiography (TTE) (Figure 1 ). Tumor location was revealed in the right atrium of 19 patients, and the tumors were attached to the interatrial septum and measurements were in the range of 40-55 mm x 60-90 mm. Tumor location was revealed in the LA of 12 patients and measured (85-100 mm x 55-60 mm), a large homogenous tumor attached to the atrial septum, which was prolapsing into the left ventricle during diastole. Mild mitral regurgitation was noted. The diastolic gradient across the mitral valve was significant. None of the patients underwentcardiac catheterization for diagnosis. A summary of the operative findings and surgical techniques is shown in Table 2 . All patients were operated on after the diagnosis of atrial myxoma was made. The operation, performed under cardiopulmonary bypass, used aortic bicaval cannulation, moderate hypothermia and antegrade blood cardioplegia. We did not manipulate the tumor before the aorta was cross clamped. The transseptal approach incision was used for the surgery. The tumor was widely excised with the base on the septum ( Figure 2 ). All four chambers were washed with cold saline and any loose tumor fragments eliminated. The surgically created atrial septal defect was repaired directly in 17 patients (54.8%) and with a bovine pericardial patch in 14 patients (45.1%). The external appearance of tumors was usually gelatinous. The tumors ranged in size from a peduncle of 6x3x7 cm to 5,5x7x9 cm (Figure 3a , b). All the myxomas were subjected to routine histopatological examination and the diagnosis of myxoma confirmed.
Statistical Analyses
Quantitative data was given as mean±Standard Deviation. Qualitative values were described by percentages.
RESULTS
The hospital mortality after excision of myxomas was 3.2% ( one patient with left atrial myxoma). This patient died due to a sudden malignant arrhythmia during the early postoperative period. The other 30 patients were followed up on an outpatients basis at regular intervals. They underwent clinical examination, rontgenography, electrocardiography and TTE. Mean follow-up was 9.8±1.4 years. There were no recurrence of myxoma and all patients' cardiac symptoms were classified in NYHA Class I.
DISCUSSION
Cardiac myxomas are benign intracavitary neoplasms with an incidence between 0.0013 and 0.03% in cardiac surgery (4, 5) . Cardiac myxomas may be localized in any of the four cardiac chamber. They are more common in the atrial chambers, especially in the LA(2), usually appear in middle age, and are more frequent in women. In our study, patients were mostly female and middle-aged similar to other studies. However, the localization of tumor were mostly in the right atrium, contrary to the other studies. This revealed similar incidences, and as in other series, a female predominance was noted with a female: male ratio of 1.4-2/1. The mean age of our patients was 46.7 years, which is in concordance with that from the literature (6-9). Clinical symptoms of myxomas were atypical and quite variable. The clinical mani- festations of myxomas depend on localization, size and speed of growth of the myxoma (8, 10) . All patients with LA myxomas presented with mitral obstructive symptoms. One patient with an LA myxoma presented with cerebral embolisation (stroke) and mitral obstructive symptoms preoperatively. All patients with RA myxomas presented with symptoms of congestive cardiac failure. Two-dimensional (2D) TTE is a safe and currently the most important diagnostic modality available for imaging cardiac tumors (11) . Transesophageal echocardiography has increased the specificity and sensitivity of diagnosis, especially in patients who have a poor transthoracic echocardiographic window. Coronary angiography should be performed in older patients who are at risk for coronary artery disease. In our series, echocardiography was uniformly successful in diagnosis of the tumor. None of the patients required coronary angiography. Surgical excision of cardiac myxomas must be performed, as soon as possible after the diagnosis is established because of the high risk of valvular obstruction or systematic/pulmonary embolisation. The reported rate of left or right sided embolic phenomena associated with cardiac myxomas varies. There is a slight difference in the reported rates of embolism of left and right sided myxomas with systemic emboli occurring in 30-45% of patients with left sided cardiac myxoma and pulmonary embolism occurring in about 10% of patients found to have right sided cardiac myxoma (6) . In right sided myxomas, multiple embolisms can give rise to pulmonary hypertension. Rarely, this can give rise to fatal pulmonary obstruction (6) . According to researchers, symptoms associated with embolic phenomena such as stroke or transient ischemic attack are more common in young adults (1 in 250) than in older patients with these problems (1 in 750) (1). Our patient with cerebral embolism was 36-year-old.
Surgical techniques for treating atrial myxoma are median sternotomy under total CPB or minimally -invasive videoassisted approaches. Tumor fragmentation, followed by embolisation of myxomatous debris, can be a serious intraoperative complication of this procedure. However, the risk of embolisation can be greatly reduced, by manipulating the heart as little as possible during cannulation and tumor excision (12) . Various surgical approaches have been reported in the literature (6, (13) (14) (15) (16) . The RA and RV myxomas are approached through the right atrium. RA myxomas demand more care during cannulation (6) . The LA approach gives a direct and fast access to the myxoma though not to its attachment (13) . The biatrial approach also allows good exploration of all the cardiac chambers (14, 15) . The transseptal approach through right atriotomy suggested by Chit wood is more practical and conservative (16) . It has been estimated that cardiac myxomas recur in 3%-7% of cases (17) (18) (19) (20) . McCarthy et al. (18) classified cardiac myxomas into three types: complex, familial and sporadic. Patients with complex and familial myxomas are characterized by a high incidence of recurrent myxomas (19) . Therefore, careful surgical management and postoperative follow-up are important for these patients. The incidence of recurrence after complete excision is 1 %-3% in patients with sporadic myxomas and thus a continuous postoperative follow-up is called for (19) . Gerbode was the first to report recurrence (20) . Recurrence can be due to inadequate resection, intraoperative implantation, embolization, or tumor seeding at the time of operation, and multiple foci of the tumor (17, 18, 20) . Recurrence may occur within a few months to several years after the initial surgical excision and most are found in the first four years. In these cases, again, a wide resec- tion of the atrial septum is recommended. Therefore, resections should be complete, including all of the pedicle and the attachment area, plus a safety margin (10, 15) . In our experience, the transseptal approach, like a biatrial incision, also allows good exposure, ease and wide resection, and visualization of all the cardiac chambers for any concomitant tumor. All of our patient myxomas were sporadic and we did not see any recurrences.
CONCLUSION
Cardiac myxomas have a variety of symptoms and signs. Obstructive symptoms are the common mode of presentation, followed by embolic manifestation. Immediate surgical treatment is indicated in all patients. The transseptal approach like a biatrial incision should be applied. Complete excision of the tumor with excision of the tissue surrounding the pedicle including endocardium is sufficient, and gives excellent early and mid-term results.
